Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001 per share
-
Shares outstanding
-
71,400,541
-
Total 13F shares
-
653,872
-
Share change
-
+653,872
-
Total reported value
-
$7,258,000
-
Price per share
-
$11.10
-
Number of holders
-
1
-
Value change
-
+$7,258,000
-
Number of buys
-
1
Institutional Holders of MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) as of Q1 2022
As of 31 Mar 2022,
MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
653,872 shares.
The largest 1 holders included
MARSHALL WACE, LLP.
This page lists
1
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.